QUESTLAB

Quest Laboratories Share Price

₹110.50 -6.85 (-5.84%)

21 Nov, 2024 14:24

SIP TrendupStart SIP in QUESTLAB

Start SIP

Performance

  • Low
  • ₹111
  • High
  • ₹118
  • 52 Week Low
  • ₹85
  • 52 Week High
  • ₹197
  • Open Price₹118
  • Previous Close₹117
  • Volume6,000

Investment Returns

  • Over 1 Month + 9.73%
  • Over 3 Month -18.15%
  • Over 6 Month + 13.92%
  • Over 1 Year + 13.92%
SIP Lightning

Smart Investing Starts Here Start SIP with Quest Laboratories for Steady Growth!

Invest Now

Quest Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 181
  • P/B Ratio
  • 6.3
  • Average True Range
  • 5.81
  • EPS
  • 6.16
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.43
  • RSI
  • 62.73
  • MFI
  • 85.45

Quest Laboratories Financials

Quest Laboratories Technicals

EMA & SMA

Current Price
₹110.50
-6.85 (-5.84%)
pointer
  • stock-down_img
  • Bullish Moving Average 9
  • stock-up_img
  • Bearish Moving Average 4
  • 20 Day
  • ₹107.00
  • 50 Day
  • ₹110.15
  • 100 Day
  • ₹119.94
  • 200 Day
  • -

Resistance and Support

117.33 Pivot Speed
  • R3 120.87
  • R2 119.68
  • R1 118.52
  • S1 116.17
  • S2 114.98
  • S3 113.82

What's your outlook on Quest Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Quest Laboratories Ltd has an operating revenue of Rs. 234.05 Cr. on a trailing 12-month basis. An annual revenue growth of 34% is outstanding, Pre-tax margin of 17% is great, ROE of 35% is exceptional. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 7% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 14 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 85 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Quest Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results & Others To consider other business matters.

Quest Laboratories F&O

Quest Laboratories Shareholding Pattern

65.83%
0.1%
0.74%
23.12%
10.21%

About Quest Laboratories

  • NSE Symbol
  • QUESTLAB
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Anil Kumar Sabarwal
  • ISIN
  • INE0TNW01017

Similar Stocks to Quest Laboratories

Quest Laboratories FAQs

Quest Laboratories share price is ₹110 As on 21 November, 2024 | 14:10

The Market Cap of Quest Laboratories is ₹181.1 Cr As on 21 November, 2024 | 14:10

The P/E ratio of Quest Laboratories is As on 21 November, 2024 | 14:10

The PB ratio of Quest Laboratories is 6.3 As on 21 November, 2024 | 14:10

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23